摘要:
Compounds of formula wherein R₁, R₂, R₃, R₄, and n have the meanings reported in the specification, processes for their preparation and pharmaceutical compositions containing them as active ingredient are described. The compounds of formula I are inhibitors of enzymatic systems and they are useful in pharmaceutical field.
摘要:
A stereoselective process for the preparation of the compounds of formula
wherein R, R₁, R₂, a and b have the meanings reported in the specification, is described. The compounds of formula I have a remarkable central analgesic activity and they are useful in the pharmaceutical field.
摘要:
Compounds of formula wherein R, R₁, R₂, R₃, R₄, R₅ and n have the meanings reported in the specification, processes for their preparation and pharmaceutical compositions containing them as active ingredient are described. The compounds of formula I are inhibitor of enzymatic systems and they are useful in pharmaceutical field.
摘要:
Compounds of formula wherein R, R₁, R₂, R₃, R₄, R₅ and n have the meanings reported in the specification, processes for their preparation and pharmaceutical compositions containing them as active ingredient are described. The compounds of formula I are inhibitor of enzymatic systems and they are useful in pharmaceutical field.
摘要:
Compounds of formula (wherein R and R₁ have the meanings reported in the specification) and their preparation are described. The compounds of formula I have anti-allergic, anti-anaphylactic and anti-arthritic activity and are useful in pharmaceutical field. Compositions for pharmaceutical use containing a compound of formula I as active ingredient are described too.